These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

943 related items for PubMed ID: 12576453

  • 1. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
    Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Y, Horvath S, Leibovich BC, Chopra S, Liao SY, Stanbridge E, Lerman MI, Palotie A, Figlin RA, Belldegrun AS.
    Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma.
    Bui MH, Visapaa H, Seligson D, Kim H, Han KR, Huang Y, Horvath S, Stanbridge EJ, Palotie A, Figlin RA, Belldegrun AS.
    J Urol; 2004 Jun; 171(6 Pt 1):2461-6. PubMed ID: 15126876
    [Abstract] [Full Text] [Related]

  • 3. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.
    Leibovich BC, Sheinin Y, Lohse CM, Thompson RH, Cheville JC, Zavada J, Kwon ED.
    J Clin Oncol; 2007 Oct 20; 25(30):4757-64. PubMed ID: 17947723
    [Abstract] [Full Text] [Related]

  • 4. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
    Stillebroer AB, Mulders PF, Boerman OC, Oyen WJ, Oosterwijk E.
    Eur Urol; 2010 Jul 20; 58(1):75-83. PubMed ID: 20359812
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma.
    Phuoc NB, Ehara H, Gotoh T, Nakano M, Kamei S, Deguchi T, Hirose Y.
    Oncol Rep; 2008 Sep 20; 20(3):525-30. PubMed ID: 18695901
    [Abstract] [Full Text] [Related]

  • 6. Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up.
    Zhang BY, Thompson RH, Lohse CM, Dronca RS, Cheville JC, Kwon ED, Leibovich BC.
    BJU Int; 2013 Jun 20; 111(7):1046-53. PubMed ID: 23551810
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature.
    Zhao Z, Liao G, Li Y, Zhou S, Zou H, Fernando S.
    PLoS One; 2014 Jun 20; 9(11):e114096. PubMed ID: 25426861
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: analysis from the treatment approaches in renal cancer global evaluation trial (TARGET).
    Choueiri TK, Cheng S, Qu AQ, Pastorek J, Atkins MB, Signoretti S.
    Urol Oncol; 2013 Nov 20; 31(8):1788-93. PubMed ID: 23141780
    [Abstract] [Full Text] [Related]

  • 13. Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy.
    Choueiri TK, Regan MM, Rosenberg JE, Oh WK, Clement J, Amato AM, McDermott D, Cho DC, Atkins MB, Signoretti S.
    BJU Int; 2010 Sep 20; 106(6):772-8. PubMed ID: 20230385
    [Abstract] [Full Text] [Related]

  • 14. Biomarker discovery in urogenital cancer.
    Said J.
    Biomarkers; 2005 Nov 20; 10 Suppl 1():S83-6. PubMed ID: 16298916
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.
    Atkins M, Regan M, McDermott D, Mier J, Stanbridge E, Youmans A, Febbo P, Upton M, Lechpammer M, Signoretti S.
    Clin Cancer Res; 2005 May 15; 11(10):3714-21. PubMed ID: 15897568
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.